Sangqi Pan

Feb 6, 2024 | jamanetwork.com | Bonaventure Ip |Zhong Yuan |Sangqi Pan |Trista Hung

Key PointsQuestion  Is prothrombin complex concentrate (PCC) treatment useful for patients who develop intracerebral hemorrhage (ICH) during direct oral anticoagulant (DOAC) usage? Findings  In this cohort study of 232 patients in Hong Kong, 31% of patients with DOAC-associated ICH achieved good neurological recovery and 39% died within 90 days. PCC treatment was not associated with neurological outcomes, hematoma expansion, or survival.